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Summary
Breast cancer is the most common malignant tumor in women in Croatia. Most of breast surgery in our country is 
performed in our surgical department. Imaging is essential for the early detection,accurate diagnosis and clinical staging of 
breast cancer. Population screening with mammography aims to reduce mortality by detecting the disease at an earlier 
stage, before it has spread beyond the breast. Mammography and ultrasound are the fi rst-line imaging investigations in 
women with breast symptoms. Magnetic resonance imaging is established as an adjunctive diagnostic tool because of its 
high sensitivity for invasive breast cancer. Percutaneous image-guided breast biopsy is used for the pathological assessment 
of breast lesions. It is used also as fi rst stage of treatement for neoadjuvant chemotherapy when breast cancer is in advanced 
stage.
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RADIOLOŠKA DIJAGNOSTIKA DOJKE
Sažetak
Karcinom dojke je najčešći zločudni tumor ženske populacije u Hrvatskoj. Većina operacija dojke u Hrvatskoj obavlja 
se u Klinici za tumore u Zagrebu. Radiološka dijagnostika je važna za rano otkrivanje, točnu dijagnozu i procjenu kliničkog 
stadija karcinoma dojke. Svrha mamografskog probira je rano otkrivanje bolesti. U primarne metode dijagnostike spadaju 
mamografi ja i ultrazvuk. Magnetska rezonanca se koristi samo kao dodatna metoda zbog svoje visoke osjetljivosti za inva-
zivni karcinom dojke. Perkutana biopsija pod kontrolom ultrazvuka se koristi za patohistološku dijagnostiku ciljane tvorbe 
u dojci i kao prvi stadij terapije kod uznapredovalog karcinoma koji se liječi neoadjuvantnom kemoterapijom.
KLJUČNE RIJEČI: karcinom dojke, mamografi ja, ultrazvuk, magnetska rezonancija, perkutana biopsija
INTRODUCTION
Im aging is essential for the early detection, 
accurate diagnosis and clinical staging of breast 
cancer. Population screening with mammogra-
phy aims to reduce mortality by detecting the 
 disease at an earlier stage. Mammography and ul-
trasound are still the fi rst-line imaging investiga-
tions in women with breast cancer symptoms. 
Magnetic resonance imaging is established as an 
additional diagnostic tool because of its high sen-
sitivity.
MAMMOGRAPHY
Breast imaging is used to screen asymptom-
atic women for early breast cancer and to evaluate 
breast abnormalities. Screen fi lm X-ray mammog-
raphy is used for screening. The standard exami-
nation for women undergoing either symptomatic 
mammography or their fi rst screening examina-
tion consists of lateral oblique (fi g 1.1) and cranio-
caudal (fi g 1.2) view of each breast.
While screening mammograms are routinely 
used to detect breast cancer in women who have 
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no apparent symptoms, diagnostic mammograms 
are used after suspicious results on screening 
mammogram or after some signs of breast cancer 
such a lump, breast pain, thickening of skin and 
changes in size or shape of breast. For interpreta-
tion lateral oblique and craniocaudal mammo-
grams should each be viewed together in a mirror-
image confi guration (fi g 1.3) which will allow ra-
diologist to scan the breast for asimetry.
Women with personal or close history of 
breast cancer are at greater risk for development 
of malignancy, andthe interpretation of mammo-
graphic fi ndings should be tailored accordingly. 
Other informations such as previous surgical bi-
opsies or hormone replacement terapy must also 
be taken into account during interpretation of the 
mammogram. Special views can image palpabile 
lesions that occur in location not included on stan-
dard mammography. Classic signs of malignancy 
are spiculated masses or pleomorphic cluster of 
microcalcifi cations (1.4), however only about 40% 
of all occult breast carcinoma present in this ways.
The ability of mammogram to detect breast 
cancer may depend on the size of the tumor, den-
sity of the breast tissueand the skill of radiologist. 
Mammography is less likely to reveal breast tu-
mor in younger women (less than 50 years old) in 
comparison to older women. This is due to a fact 
that younger women have denser breast tissue 
which can obscure the tumorbecause breast tis-
suehas similar density (apperas white on mam-
mograms, fi g 1.5) as tumors or some other le-
sions,making them harder to detect.
Fig 1.1. The lateral oblique 
mammogram.
Fig 1.2. The craniocaudal 
mammogram.
Fig 1.3. The mirror-image confi guration.
Fig 1.4. The pleomorphic cluser of microcalcifi cations.
Fig 1.5. The mammo-
gram of young women.
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ULTRASOUND
When a suspicious fi nding is detected in 
breast through a breast self-examination or on a 
mammogram, the att endingphysician may re-
quest an ultrasound of the breast tissue. Ultra-
sound is also a primary tool for investigation of 
breast lesions in younger women or women with 
dense breast tissue. A breast ultrasound is anex-
amination that uses high frequency sound waves. 
Higher frequency ultrasound using 10-13 MHz 
probes with elastography is becoming more wide-
ly available and allows higher resolution imaging 
which gives more information.
Elastography is objective deep palpation of 
breast tissue. It maps elastic properties of soft tis-
sue in scale and color. Cancerous tumors will of-
ten be harder than the surrounding soft tissue 
(harder tissue is red in this picture) or benign tu-
mors such a fi broadenoma (softer tissue is blue in 
this picture). The subcutaneous fat layer is dem-
onstrated anteriorly as a low-refl ective tissue com-
pared to the glandular tissue.
The ultrasound appearence of the breast tis-
sue depends on how much involution of the glan-
dular tissue has taken place. The pregnant or lac-
tating breast is almost entirely composed of high-
refl ecting glandular tissue due to the glandular 
proliferation. The breast tissue defects ultrasound 
waves causing echoes which computer uses to 
make an image of what is going inside the breast 
tissue.A mass fi lled with liquid shows up diff rent-
ly than a solid mass, so breast ultrasound can pro-
vide evidence about whether the lump is a solid 
mass, a cyst fi lled with fl uid, or a combination of 
the two. While cysts are tipically not cancerous, a 
solid mass may be a fi broadenoma or a cancerous 
tumor. Ultrasound is also used tu measure exact 
size and location of the lump and surrounding tis-
sue.
Ultrasound guided percutaneous breast bi-
opsy is a widely used tehnique for an accurate his-
topatological assessment of suspected breast pa-
thology. It is a fast and safe procedure.
MAGNETIC RESONANCE IMAGING (MRI)
Dynamic contrast-enhanced magnetic reso-
nance imaging (MRI) of the breast has been shown 
Fig 2.1. The elastography of the breast tissue.
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to be extremely sensitive in the detection of inva-
sive breast cancer and is not limited by breast tis-
sue density (fi g 3.1). Enhanced means that in this 
procedure intravenous contrast is always used. 
Current indications include high-risk screening, 
evaluation for an unknown primary carcinoma, 
postoperative evaluation in patients with known 
breast cancer 6 months after surgery or follow up 
one year after radiation therapy, evaluating re-
sponse to neoadjuvant therapy, and suspected re-
currence. However, the utility of MRI has been 
limited by its variable sensitivity for ductal carci-
noma in situ (DCIS). In general, the role of MRI as 
a problem-solving tool in the evaluation of suspi-
cious imaging or clinical fi ndings is unclear. A 
negative MRI should not be used to avoid biopsy 
of suspicious fi ndings on mammography or ultra-
sound or suspicious clinical fi nding
EVALUATION
The Breast Imaging Reporting and Data Sys-
tem (BI-RADS) lexicon is a classifi cation scheme 
used to help standardize the description and dis-
position of breast lesions seen on mammography, 
ultrasound, and MRI. BI-RADS categories 1 and 2 
are used to describe a negative study and a study 
in which there are benign fi ndings. Category 3 is 
used to describe probably benign fi ndings, with a 
Fig 3.1.The dynamic contrast-enhanced MRI of the breast.
less than 2% chance of malignancy, which can be 
followed in 6 months. Patients with new or enlarg-
ing solid masses or increasing clustered microcal-
cifi cations that are not classically benign require 
biopsy. Category 4 is used to describe suspicious 
fi ndings (greater than 2% chance of malignancy) 
that require biopsy. BI-RADS category 5 lesions 
are highly suspicious fi ndings, having a 95% or 
higher likelihood of malignancy. Category 6 is 
used in patients with a known breast cancer who 
are undergoing neoadjuvant chemotherapy or ad-
ditional imaging studies. If mammography is de-
scribed with BI-RADS 3 or 4 additional imaging 
with ultrasound is required. If ultrasound is 
scored with BI-RADS3 or 4 than fi ne needle aspi-
ration or percutaneous image-guided breast bi-
opsy is recomended. With BI-RADS 5 biopsy is 
warranted. BI-RADS clasifi cation should be a part 
of every radiologist report in an eff ort to stan-
darize image reporting and to reduce confusion in 
report interpretation between physicians.
In our radiology department more than 12000 
breast ultrasound, over 12000 mammographies 
and two thousand breast MRI are preformed each 
year, most of which are used for pre and postop-
erative evaluation. These enable us to confi dently 
work as a part of well establishe dmultidisci-
plinary trem. We consider that expirience, volume 
and multimodal aproach is most important in 
evaluating breast patology.
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